We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quincy Bioscience Begins Recruitment for Migraine Study
News

Quincy Bioscience Begins Recruitment for Migraine Study

Quincy Bioscience Begins Recruitment for Migraine Study
News

Quincy Bioscience Begins Recruitment for Migraine Study

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Quincy Bioscience Begins Recruitment for Migraine Study"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Online Migraine Trial is a patient-rated outcomes study in which participants complete validated rating scales via the internet over a three month period of time.  Migraineurs 18 to 50 years old who experience 3 or more migraines per month are encouraged to apply at www.onlinemigrainetrial.com.

Apoaequorin is a naturally-sourced calcium-binding protein which has proven neuroprotective by its ability to help to regulate intracellular calcium levels.  High levels of intracellular calcium are believed to be one cause of the cortical spreading depression associated with migraine headaches.

Migraines are a chronic neurological disease and affect over 30 million adult Americans, with women three times more likely to suffer from recurring migraines.

The study offers migraine sufferers the opportunity to enroll and participate from their own homes.  Unlike conventional trials which may require blood draws and clinic visits, the Online Migraine Trial is non-invasive and is convenient to participate.

Advertisement